As of 2025-07-04, the EV/EBITDA ratio of Willow Biosciences Inc (WLLW.TO) is -1.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WLLW.TO's latest enterprise value is 4.48 mil CAD. WLLW.TO's TTM EBITDA according to its financial statements is -2.86 mil CAD. Dividing these 2 quantities gives us the above WLLW.TO EV/EBITDA ratio.
Range | Selected | |
Trailing P/E multiples | 1.4x - 2.1x | 1.8x |
Forward P/E multiples | 1.5x - 2.1x | 1.8x |
Fair Price | (0.31) - 7.12 | 2.80 |
Upside | -217.6% - 2587.2% | 957.3% |
Date | EV/EBITDA |
2025-07-02 | -1.57 |
2025-06-30 | -1.64 |
2025-06-27 | -1.75 |
2025-06-26 | -1.59 |
2025-06-25 | -1.33 |
2025-06-24 | -1.82 |
2025-06-23 | -1.23 |
2025-06-20 | -1.10 |
2025-06-19 | -0.97 |
2025-06-18 | -0.97 |
2025-06-17 | -0.97 |
2025-06-16 | -0.97 |
2025-06-13 | -0.97 |
2025-06-12 | -0.97 |
2025-06-11 | -0.97 |
2025-06-10 | -0.97 |
2025-06-09 | -1.10 |
2025-06-06 | -1.10 |
2025-06-05 | -0.97 |
2025-06-04 | -0.97 |
2025-06-03 | -0.97 |
2025-06-02 | -0.97 |
2025-05-30 | -1.10 |
2025-05-29 | -0.97 |
2025-05-28 | -1.10 |
2025-05-27 | -0.97 |
2025-05-26 | -0.97 |
2025-05-23 | -1.10 |
2025-05-22 | -1.10 |
2025-05-21 | -1.23 |
2025-05-20 | -1.10 |
2025-05-16 | -0.97 |
2025-05-15 | -1.10 |
2025-05-14 | -1.10 |
2025-05-13 | -0.97 |
2025-05-12 | -1.10 |
2025-05-09 | -1.10 |
2025-05-08 | -1.23 |
2025-05-07 | -0.97 |
2025-05-06 | -0.46 |
2025-05-05 | -0.46 |
2025-05-02 | -0.46 |
2025-05-01 | -0.33 |
2025-04-30 | -0.33 |
2025-04-29 | -0.33 |
2025-04-28 | -0.33 |
2025-04-25 | -0.33 |
2025-04-24 | -0.33 |
2025-04-23 | -0.33 |
2025-04-22 | -0.33 |